Epcoritamab can now be accessed as an option to treat relapsed or refractory follicular lymphoma in adults after 2 or more lines of systemic treatment, only if epcoritamab is stopped after 3 years of ...
A formal appeal has been sent to the NHS spending watchdog regarding its decision to remove a potentially life-saving cancer treatment from the health service in England and Wales. Tecartus – which ...
The therapeutic landscape for cutaneous T-cell lymphoma (CTCL) is undergoing a significant shift with the emergence of denileukin diftitox (Lymphir), the first systemic treatment ...
Missouri judge pre-approves settlement, but full approval and payouts still months away ...
Bristol Myers Squibb (BMY) stock is in focus as the FDA expands the label for cancer drug Opdivo as a first-line therapy for Hodgkin lymphoma. Read more here.
The Miami Hurricanes defeated the Missouri Tigers in the first round of the 2026 NCAA tournament. Follow live updates from ...
3don MSN
Rock star reveals cancer diagnosis, but vetoes treatment: ‘Still got 2-3 years to say goodbye’
British rock band The Wildhearts announced this week that its frontman and founding member, Ginger Wildheart, has been diagnosed with Mantle Cell Lymphoma, a rare but aggressive form of cancer. The ...
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Allen was diagnosed with Non-Hodgkin Lymphoma in December, but he seems to be in the home stretch of treatment.
Allen — who was diagnosed with non-Hodgkin lymphoma in December and ruled out for the rest of the season — has been around his team as much as possible since beginning treatment and got the postgame ...
Seeger Weiss LLP, Motley Rice LLC, Waters Kraus Paul & Siegel, Williams Hart & Boundas LLP, The Holland Law Firm, and Ketchmark & McCreight P.C. announce that the Circuit Court of the City of St.
Soligenix Announces HyBryte™ Clinical Summary Published in "Expert Opinion on Investigational Drugs"
(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results